Microbial Symphony: Understanding Biochemical Pathways for Precision Medicine and Beyond

Year : 2025 | Volume : 02 | Issue : 01 | Page : 28-43
    By

    Dr B Sheshu Kumar,

  • Dr. A. Mrudula Srinivasulu,

  1. Associate Professor, Prathima Institute Of Medical Sciences, Karimnagar, Telangana, India
  2. Assistant Professor, Prathima Institute Of Medical Sciences, Karimnagar, Telangana, India

Abstract

The human microbiome, an intricate ecosystem of microorganisms inhabiting the body, is a key regulator of host biochemistry and physiology. This review delves into the complex biochemical pathways influenced by the microbiome, spotlighting critical metabolites like short-chain fatty acids, bile acids, and tryptophan derivatives, which impact immune regulation, energy metabolism, and neurobehavioral functions. By examining interactions between the microbiome and the host, including the influence of genetic factors and metabolite-driven communication networks, this work underscores the microbiome’s pivotal role in sustaining health and its involvement in the development of diseases such as metabolic disorders, cancer, and neurological conditions. Recent advancements in multi-omics technologies, synthetic biology, and AI-driven analytics have significantly advanced microbiome research. These innovations have facilitated the discovery of novel biomarkers, the creation of microbiome-targeted therapies, and the engineering of synthetic microbial communities for therapeutic purposes. The review also highlights the expanding relevance of non-gut microbiomes—such as those in the skin, oral cavity, and respiratory system—and their systemic impacts, broadening the traditional scope of microbiome research. By integrating historical milestones, current progress, and future opportunities, this review emphasizes the transformative potential of microbiome science in diagnostics, therapeutics, and biotechnological applications. Addressing unresolved issues, including inter-kingdom dynamics, environmental factors, and the need for regulatory frameworks, is essential to fully leverage the microbiome’s capabilities. Ultimately, this review positions the microbiome as a cornerstone of precision medicine, paving the way for innovative approaches to chronic disease management, health optimization, and solutions to global sustainability challenges.

Keywords: Human microbiome, SCFAs, bile acids, immune modulation, energy metabolism, multi- omics, synthetic biology, precision medicine, biomarkers, diagnostics.

[This article belongs to International Journal of Antibiotics ]

How to cite this article:
Dr B Sheshu Kumar, Dr. A. Mrudula Srinivasulu. Microbial Symphony: Understanding Biochemical Pathways for Precision Medicine and Beyond. International Journal of Antibiotics. 2024; 02(01):28-43.
How to cite this URL:
Dr B Sheshu Kumar, Dr. A. Mrudula Srinivasulu. Microbial Symphony: Understanding Biochemical Pathways for Precision Medicine and Beyond. International Journal of Antibiotics. 2024; 02(01):28-43. Available from: https://journals.stmjournals.com/ijab/article=2024/view=186418


References

  1. Den Besten G, Van Eunen K, Groen AK, Venema, K. The role of short-chain fatty acids in diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–2340. https://doi.org/10.1194/jlr.R036012
  2. Cryan JF, O‘Riordan KJ, Sandhu K, Peterson VL, & Dinan TG. The gut-brain axis: Microbiome influences on neurological health. Physiol Rev. 2019;99(4):1877–2013. https://doi.org/10.1152/physrev.00018.2018
  3. Heinken A, Sahoo S, Fleming RMT, Thiele I. Reconstructing metabolic networks to map host-microbiome interactions. Nat Rev Microbiol. 2015;13(5):259–275. https://doi.org/10.1038/nrmicro3484
  4. Pasteur L, Joubert JB, Chamberland C. On the germ theory and its application to medicine. Medical Classics.
  5. Koch R, Loeffler F, Gaffky G. The etiology of infectious diseases. Berliner Klinische Wochenschrift; 1884.
  6. Woese CR, Kandler O, Wheelis ML. RNA sequencing for phylogeny: A critical tool in microbiome research. PNAS. 1980;77(8):4943–4947. https://doi.org/10.1073/pnas.77.8.4943
  7. Tyson GW, Chapman J, Hugenholtz P. Community genome sequencing in environmental microbiomes. 2004;428(6978):37–43. https://doi.org/10.1038/nature02339
  8. Zschocke S, Jensen J, Weisser J. The role of AI in microbiome research: Opportunities and challenges. 2021;9(1): 150–165. https://doi.org/10.1186/s40168-021-01078-4
  9. Xiao L, Wang Q, Liu J, Li W. Short-chain fatty acids in health and disease: A review. J Mole Med. 2021;99(4):497–513. https://doi.org/10.1007/s00109-021-02083-w
  10. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J. Microbiota-produced SCFAs regulate glucose homeostasis via GLP-1 secretion. Nat Commun. 2014;5:5496. https://doi.org/10.1038/ncomms6496
  11. Belkaid Y, Hand TW, Pulendran, B. Role of the microbiota in immunity and inflammation. 2014;157(1):121–141. https://doi.org/10.1016/j.cell.2014.03.011
  12. Parks BW, Nam E, Org E, Kostka D. Microbiome-host interactions in health and disease: Mechanisms and therapeutic opportunities. Cell Host & Microbe. 2020;28(3):350–364. https://doi.org/10.1016/j.chom.2020.01.002
  13. Loomba R, Seki E, Handa P. Non-alcoholic fatty liver disease and the gut microbiome. J Hepatol. 2020;73(1):151–166. https://doi.org/10.1016/j.jhep.2020.02.025
  14. Yano JM, Yu K, Donaldson GP, Shastri GG. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. 2015;161(2):264–276. https://doi.org/10.1016/j.cell.2015.02.047
  15. Mayer EA, Knight R, Mazmanian SK, Cryan JF. Gut/brain axis and the microbiota. J Clin Invest. 2015;125(3):926–938. https://doi.org/ 10.1172/JCI80046
  16. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom, G. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLOS ONE, 2013;8(2):56936. https://doi.org/10.1371/journal.pone.0056936
  17. Ley RE, Turnbaugh PJ, Klein S, Gordon J I. Obesity alters gut microbial ecology. 2005;10231:11070–11075. https://doi.org/10.1073/pnas.0505402102
  18. Fujita Y, Hata T, Nakashima S. Microbiome and cancer: Current state and perspectives. Cancer Sci. 2022;113(4):1210–1220. https://doi.org/10.1111/cas.15234
  19. Gonzalez J, Verderosa A, Svensson R. The immune response in tuberculosis. Lancet Infect Dis. 2003;3(11):652–659. https://doi.org/10.1016/S1473-3099(03)00866-6
  20. Scriba TJ, Wilkinson RJ, Walz lG. Host-directed therapies for tuberculosis. Lancet Respiratory Med. 2017;5(5):414–423. https://doi.org/10.1016/S2213-2600(16)30467-3
  21. Scollard DM, Adams LB, Gillis TP. Leprosy and chronic inflammation. Lancet Infect Dis. 2006;6(4):213–222. https://doi.org/10.1016/S1473-3099(06)70409-1
  22. Haugen T, Silwal P, Acharya P. Role of immune response in leprosy. Clin Immunol. 2015;35(5):529–538. https://doi.org/10.1007/s10875-015-0167-3
  23. Miller SE, Rojas JR, Hernandez AL. Rickettsial infections and inflammation. Clin Microbiol. 2017;55(5):1226–1234. https://doi.org/10.1128/JCM.00032-17
  24. Buitrago D, Lopez-Garcia R ,Garcia JL. Fungal diseases: Mechanisms of immune evasion and inflammatory response. J Fungal Dis. 2015;43(3):450–461. https://doi.org/10.1093/mmy/myv057
  25. Cohen J, Haimovich A, Mizrahi B. Malaria: Mechanisms of immunity and disease pathogenesis. Nat Rev Immunol. 2010;10(1):66–77. https://doi.org/10.1038/nri2674
  26. Sokolow SH, Jones IJ, Sing KK. Schistosomiasis and chronic inflammation: Implications for cancer. Cell Molecul Immunol. 2019;16(8):646–658. https://doi.org/10.1038/s41423-019-0227-y
  27. Cani PD, Amar J, Iglesias MA. Endotoxemia contributes to inflammation in obesity. Diabetes, 2008;57(11):2982–2990. https://doi.org/10.2337/db08-0349
  28. Charbonneau MR, Blanton LV, DiGiulio DB Engineering probiotics for therapeutic applications. Nat Rev Microbiol. 2020;18(5):346–359. https://doi.org/10.1038/s41579-020-0322-1
  29. Kang DW, Adams JB, Gregory AC. Long-term benefits of microbiota transfer therapy on autism symptoms and gut microbiota. Scientific Reports. 2019;9(1):5821. https://doi.org/10.1038/s41598-019-42183-0
  30. Trivedi PJ, Hirschfield GM, Gershwin ME. Treatment of primary biliary cholangitis: Current and future perspectives. Hepatol Int. 2016;10(1):1–17. https://doi.org/10.1007/s12072-015-9652-7
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 21/11/2024
Accepted 24/11/2024
Published 30/11/2024
Publication Time 9 Days
Total Visits: 169


My IP

PlumX Metrics